Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Increasing Blood Pressure During Gastric ESD to Control Postoperative Bleeding
NCT03070665Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Apr 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of norepinephrine in gastric neoplasms (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Post-ESD bleeding at 60 days. Status: unknown.
02
Drugs
norepinephrine
03
Conditions
gastric neoplasms
Beyond the preview
Go deeper on NCT03070665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03070665.